MENU
ALXO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ALX Oncology Holdings (ALXO) Earnings Date & Reports

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials... Show more

A.I. Advisor
published Earnings

ALXO is expected to report earnings to fall 5.64% to -51 cents per share on May 08

ALX Oncology Holdings ALXO Stock Earnings Reports
Q1'25
Est.
$-0.52
Q4'24
Beat
by $0.12
Q3'24
Beat
by $0.20
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.11
The last earnings report on March 06 showed earnings per share of -55 cents, beating the estimate of -67 cents. With 561.14K shares outstanding, the current market capitalization sits at 32.67M.
View a ticker or compare two or three
ALXO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the research and development of therapies for cancer patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
323 Allerton Avenue
Phone
+1 650 466-7125
Employees
72
Web
https://www.alxoncology.com